
Please try another search
Simcere Pharmaceutical Group Limited, an investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products to distributors, pharmacy chains, and other pharmaceutical manufacturers in China. The company focuses on various therapeutic areas, including oncology, central nervous system, autoimmune, anti-infection, cardiovascular, and others. Its principal products include Sanbexin, an edaravone and dexborneol concentrated solution for injection; Endostar, a recombinant human endostatin injection; ENWEIDA, an envafolimab injection; COSELA, a trilaciclib hydrochloride for injection; Iremod, an iguratimod tablet; and XIANNUOXIN simnotrelvir tablets and ritonavir tablets. The company also offers promotional services for pharmaceutical products. In addition, it engages in the manufacture of pharmaceutical ingredients and its property management business. The company was founded in 1995 and is headquartered in Nanjing, China.
Name | Age | Since | Title |
---|---|---|---|
Jinsheng Ren | 63 | 1995 | Co-Founder, Chairman & CEO |
Yushan Wan | 55 | 2019 | CFO, Joint Company Secretary & Executive Director |
Renhong Tang | 44 | 2019 | Executive Director |
Ruilin Song | 61 | 2019 | Independent Non-Executive Director |
Xinhua Wang | 69 | 2019 | Independent Non-Executive Director |
Jianguo Wang | 65 | 2019 | Independent Non-Executive Director |
Ka Woon Sung | 53 | 2023 | Independent Non-Executive Director |
Xi Wang | 42 | 2023 | VP & Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review